N-Strategy Consulting Services to Accelerate and Invest In Neurametrix Asia-pacific Market Entry
NeuraMetrix, Inc. and N-Strategy Consulting Services [NSCS] have entered into an agreement where NSCS, with its founder and CEO Nathanael Noiraud, will accelerate and invest in NeuraMetrix’s Asia-Pacific market entry.
FDA Grants Breakthrough Device Designation to Neurametrix
37th Annual J.P. Morgan Healthcare Conference in San Francisco, California: The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the NeuraMetrix brain health monitoring solution.
NeuraMetrix is a San Francisco based Medical Device company. It offers a novel, unique, highly accurate software tool for monitoring of a range of Neurological diseases and Psychiatric disorders over time.
